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BRIEF DEFINITIVE REPORT
        T cell production is maintained throughout life 
by thymic seeding by BM-derived progenitors, 
although this process does decline in intensity 
with age (  1  ). The identifi  cation of postnatal 
lymphoid progenitors is of crucial importance 
for both basic and applied research, because they 
may help us to understand and correct defects 
in T cell development. In humans, the nature 
of the progenitors that seed the adult thymus is 
poorly known, mainly because of experimental 
limitations. Most of our knowledge derives from 
extensive in vitro and in vivo studies performed 
in mice. Weissman  ’  s model proposes that B, NK, 
and T lymphoid cells are derived from a common 
lymphoid progenitor (CLP). Indeed, a popu-
lation of mouse BM cells harboring a Lin        c-
kit  lo  terminal deoxynucleotide transferase (TdT)  +
  IL-7R       +/lo   phenotype has been shown to be de-
void of any   ery  throid and myeloid potential while 
maintaining lymphoid diff  erentiation capacity 
and, thus, has been referred to as a CLP (  2, 3  ). 
However, CLPs were never detected in the 
blood (  4  ), and subsequent investigations re-
vealed that BM precursors other than CLPs 
might seed the thymus. Krueger et al. identifi  ed 
a CLP2 population that can effi   ciently seed the 
thymus after in  travenous injection (  5  ). More-
over, within the most primitive Lin        Sca1  +  c-kit  +   
hematopoietic progenitors, several populations 
were shown to have both the capacity to home 
to the thymus and generate T cells (  6  –  9  ). Inside 
the thymus, several canonical T progenitors  —
  the early thymic progenitors (ETPs) and two sub-
sets of the DN1 population  —  could be derived 
from thymic seed  ing progenitors (  4, 8, 10  ). Col-
lectively, these fi  ndings suggest that diff  erent types 
of BM pro  genitors can reconstitute the thymus 
under experimental conditions (  4  ), but the relative 
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on Lin        CD34  +   cells both in cord blood and BM at various 
ages (Fig. S1, A and B, available at http://www.jem.org/cgi/
content/full/jem.20071003/DC1). Although cord blood 
contained both CD7  +   and CD10  +   cells, only CD10  +   cells 
were detected in all BM samples. We showed that the major-
ity of Lin        CD34  +   cells were CD10  +   in the cord blood (59.5   ±   
19.6%) and in BM from donors   <  10 yr of age (64   ±   18.6%), 
and that the proportion of this cell population decreased to 
19   ±   13.9% in donors   >  10 yr of age (Fig. S1 C). The propor-
tion of CD10  +   cells was estimated to be 1 in 350 and 1 in 
1,170 mononuclear cells in the BM of donors   <  10 or   >  10 yr 
of age, respectively. Thus, in contrast to what we and others 
observed during the fetal period, when both CD10  +   and 
CD7  +  CD45RA  +   progenitors coexist (  11  –  13, 18  ), our phe-
notypic characterization of postnatal samples indicates that 
only CD10  +   progenitor cells are present during this period 
(even up to 57 yr of age). 
  Postnatal CD10  +   progenitors have no erythroid and very 
limited myeloid differentiation potential but exhibit 
a strong lymphoid potential 
  CD10         and CD10  +   cells sorted from BM and cord blood 
samples were cultured in semisolid medium to assess their 
myeloid and erythroid potential. CD10         progenitors ex-
hibited a high erythroid clonogenic potential and a lower 
myeloid one, and was also able to generate a significant 
proportion of mixed colonies (Table S1, available at http://
www.jem.org/cgi/content/full/jem.20071003/DC1). In con-
trast, under the same culture conditions, no colonies grew 
from CD10  +   progenitors. This result was confi  rmed by co-
culture on MS5 stromal cells (Table S2). Collectively, these 
results indicate that the erythro-myeloid potential of post-
natal CD10  +   progenitors is very low as compared with 
CD10         progenitors. 
  We next tested the lymphoid potentials of CD10  +   and 
CD10         progenitors by culture in B and NK cell conditions. 
Irrespective of donor age, CD10  +   progenitors sorted from 
either cord blood or BM gave rise to high numbers of CD19  +   
and CD56  +   cells, whereas CD10         progenitors generated 
only a few lymphoid cells (Fig. S2, A and B, available at 
http://www.jem.org/cgi/content/full/jem.20071003/DC1). 
The T cell diff  erentiation potential of CD10  +   and CD10         
progenitors was tested by using co-cultures on OP9-hDelta1 
stromal cells. CD10  +   cells generated T lymphocytes more 
effi   ciently than CD10         cells regardless of their ontogenic 
origin (BM or cord blood; Fig. S2 C). In addition, kinetics 
of T cell diff  erentiation were diff  erent between both popu-
lations of progenitors. Indeed, CD4  +  CD8  +   double-positive 
and mature            T cells were detectable after 3 wk of cul-
ture of cord blood  –  sorted CD10  +   progenitors (Fig. S2 D). 
In contrast, CD10         progenitors gave rise to low numbers 
of immature and mature T cells in the same culture con-
ditions. Collectively, our results show that postnatal CD10  +   
cells have a very high lymphoid potential in contrast to 
CD10         cells, thus confi  rming the data published by Galy 
et al. (  15  ). 
contributions from each population to the physiological thymic 
input remain diffi   cult to assess. 
  Two groups have identifi  ed lymphoid progenitors in hu-
man umbilical cord blood (  11  –  13  ). The minor population 
of CD34  hi  CD45RA  hi  CD7  +   hematopoietic progenitor cells 
described by Haddad et al. in the fetal BM and in the cord 
blood is T/NK lineage polarized and might correspond to 
candidate prethymocytes (  12, 13  ). This population is pres-
ent in the fetal BM but declines around birth, leaving open 
the question as to which type of progenitor seeds the thy-
mus thereafter. 
  20 yr ago, Hokland et al. isolated Lin        CD10  +   progenitors 
from fetal BM. After culture on irradiated feeder thymocytes, 
these CD10  +   progenitors underwent the primary steps in T 
cell diff  erentiation (  14  ). More recently, Galy et al. refi  ned the 
pheno  typic characterization of this population and demon-
strated that a Lin        CD34  hi  CD45RA  +  CD10  +   population is 
also present in the BM after birth. These progenitors lacked 
erythroid, myeloid, and megakaryocytic potential but con-
tained a broad B, T, and NK cell and DC diff  erentiation 
potential, suggesting that this population might correspond 
to the human postnatal CLP (  15  ). However, further studies 
concluded that BM CD19        CD34  +  CD10  +   cells were rela-
tively B cell committed, based on the presence of partial DJ  H   
rearrangements and gene expression profi  le analysis (  16  –  18  ). 
It must be noted that these studies did not evaluate the T cell 
potential of this cell subset, mainly because of the lack of an 
effi   cient in vitro T cell diff  erentiation assay at the time (  19, 20  ). 
Moreover, the ability of this CD10  +   population to seed the 
thymus was not assessed. 
  Comparing the characteristics of progenitors isolated from 
BM to those of immature precursors present in the thymus 
should help identify the human T lymphocyte progenitors. 
Interestingly, early studies showed that a fraction of CD2         
thymocytes does express CD10 (  21  ). Later, thymus-seeding 
progenitor candidates were identifi  ed in the most immature 
population of the postnatal thymus, characterized by its CD34  + 
CD4        CD8        CD3         triple-negative phenotype (  22  ). Several 
groups fulfi  lled the characterization of the early steps of postnatal 
thymopoiesis and showed that the most immature thymocytes 
were also CD1a        , CD7  +  , and CD38  dim   and were able to gener-
ate T, B, and NK cells, DCs, and myeloid cells in vitro (  23  –  26  ). 
Thus, the thymus-seeding progenitor should probably form part 
of the CD34  +  CD1a        CD7  +   thymic population (  27  ). 
  In this report, we set out to identify a postnatal lymphoid 
progenitor present in the cord blood as well as in the BM, the 
blood, and the thymus at various ages. We were able to isolate 
and characterize a subset of the lymphoid-restricted Lin        CD34  + 
CD10  +   population that displays the expected characteristics of 
a postnatal, physiological B, NK, and T cell progenitor. 
    RESULTS AND DISCUSSION   
  Lin       CD34  +  CD10  +   progenitors can be detected 
throughout the postnatal period 
  To evaluate the presence of lymphoid progenitors postna-
tally, CD10 and CD7 expression were analyzed after gating JEM VOL. 204, December 24, 2007  3087
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various Lin        CD34  +   subpopulations (  Fig. 1 B  ). Only a minority 
of CD10         and CD10  +  CD24         cells express CCR9. On the 
other hand, CCR7 was detected on the surface of a signifi  cant 
fraction of CD10  +  CD24         cells, whereas it was completely 
absent on both other subpopulations. 
  Comparative analysis of CD10  +  CD24         and CD10  +  CD24  +   
populations also unraveled distinct diff  erentiation potentials. In 
bulk cultures, CD10  +  CD24         cells gave rise to B, NK, and T cells 
(  Fig. 2, A and B ).   In addition, they exhibited an enriched DC po-
tential (  Fig. 2 C  ). To note, a few   IgH   DJ and VDJ rearrangements 
were detected in CD10  +  CD24         cells (Table S3, available 
at http://www.jem.org/cgi/content/full/jem.20071003/DC1), 
whereas they were absent in CD10         progenitors. 
  NK progenitor frequency remained constant with age 
(1 in 40 for cord blood, 1 in 68 for   <  10 yr of age, and 1 in 58 
for   >  10 yr of age;   Fig. 2 D  ). In contrast, the cord blood 
CD10  +  CD24         fraction demonstrated a high T cell potential 
(1 in 20) that decreased with age (1 in 82 and 1 in 165 in 
  <  10- and   >  10-yr-of-age BM samples, respectively), and a 
low B cell potential (1 in 87) that increased with age (1 in 12 
and 1 in 25 for   <  10- and   >  10-yr-of-age BM samples, respec-
tively;   Fig. 2 D  ). These frequencies, together with the pres-
ence of complete   IgH   VDJ (which was never observed in 
human mature T cells), suggest that the CD10  +  CD24         pop-
ulation might still be heterogeneous and may consist of real 
lymphoid progenitors as well as more committed precursors. 
Additional markers may help to resolve this heterogeneity 
and to test the lineage potentials in clonal assays. 
  In contrast to CD10  +  CD24         progenitors, CD10  +  CD24  +   
cells appeared exclusively restricted to the B cell lineage. In-
deed, in bulk cultures, CD10  +  CD24  +   cells fully diff  erentiated 
into CD19  +   cells but were unable to give rise to any other 
lineages (  Fig. 2 A  ), even when plated at higher cell numbers 
(not depicted).   IgH   DJ and VDJ rearrangements were found 
much more frequently in the CD10  +  CD24  +   population as 
compared with CD10  +  CD24         cells (Table S3). 
  Collectively, these results indicate that CD24 expression 
in Lin        CD34  +  CD10  +   progenitors defi  nes a major cell popu-
lation that is completely restricted and already committed to 
B cell lineage, whereas the full B, NK, and T cell potential 
previously described for CD10  +   cells (  15  ) can be ascribed to 
the CD10  +  CD24         subset. Thus, the subdivision of CD10  +   
progenitors into CD24         and CD24  +   subsets probably ac-
counts for the controversial results described in the Introduc-
tion, because the vast majority of CD10  +   progenitors express 
CD24 and are thus B cell committed. It is noteworthy that, 
in mice, CD24 expression also coincides with the presence of 
a B cell potential both in the BM and in thymocyte popula-
tions (  8, 29  ). The current model of postnatal hematopoiesis 
based on segregation between lymphoid and myeloid path-
ways in mice may be similar in humans (  2, 30  ). 
  Postnatal CD10  +  CD24        progenitors are present in the blood 
and the thymus 
  Lin        CD34  +  CD10  +   cells were found in the blood of both 
pediatric and adult donors at an average frequency of 1 in 1,540 
  CD24 expression on postnatal CD10  +   progenitors enables 
the isolation of a B cell  –  restricted subpopulation and 
the purifi  cation of a CD10  +  CD24        subset exhibiting 
a broad lymphoid potential 
  The full lymphoid potential of CD10  +   progenitors demon-
strated by Galy et al. in 1995 (  15  ) was later challenged by sev-
eral studies concluding that these cells were committed to the 
B cell diff  erentiation pathway (  12, 16  –  18  ). Thus, the expression 
of specifi  c lymphoid precursor markers, CD45RA, CD62L, 
IL-7R     , CD25 (not depicted), and CD24 (  Fig. 1 A  ), was an-
alyzed to evaluate the degree of heterogeneity of the CD10  +   
subset.   We observed that CD24 expression divided the CD10  +   
population into two distinct cell types. To begin with, a high 
proportion of CD10  +   progenitors expressed CD24. Moreover, 
irrespective of donor age, CD24 expression correlated with 
higher CD10 expression levels, particularly in BM samples 
from young donors (  Fig. 1 A  ). We analyzed the expression of 
CC chemokine receptor (CCR) 7 and 9, which are involved 
in homing to the thymus in mice (  6, 28  ), at the surface of the 
    Figure 1.         Flow cytometry analysis of cord blood and postnatal BM 
Lin        CD34  +   progenitors.   Mononuclear cells from postnatal BM and CD34  + -
enriched cord blood were stained with a combination of lineage (Lin) markers 
and anti-CD34, anti-CD10, and anti-CD24 antibodies. (A) Representative anal-
ysis of CD10 and CD24 expression of gated Lin       CD34 +   cells from cord blood 
and BM of young (  <  10 yr of age) and older (10  –  60 yr of age) donors. (B) CCR9 
and CCR7 expression of gated Lin       CD34 + CD10      ,  Lin      CD34 + CD10 + CD24      ,  and 
Lin       CD34 + CD10 + CD24 +   cells (shaded histogram). The dotted line indicates 
control isotypes. Numbers in A and B represent percentages of cells.    3088 HUMAN POSTNATAL LYMPHOID PROGENITORS | Six et al.
blood- nor thymus-derived Lin        CD34  +  CD10  +   cells expressed 
CD24 (unpublished data), suggesting that B cell  –  committed 
CD10  +  CD24  +   cells do not circulate, in contrast to their 
and 1 in 5,700 mononuclear cells, respectively (  Fig. 3 A  ).   
CD10  +   also constituted a sizeable proportion of Lin        CD34  +   
cells recovered from the thymus (  Fig. 3 C  ). Neither adult 
    Figure 2.         Differentiation potential of CD10  +  CD24            and CD10           CD24  +   progenitors.   (A) Flow cytometry analysis of 3-wk cultures on MS5 stromal 
cells in B or NK cell differentiation assays of CD10  + CD24        and  CD10 + CD24 +   progenitors sorted from   <  10-yr-old BM. The data shown represent six inde-
pendent experiments performed on cord blood (  n   = 2) and   <  10-yr-old (  n   = 2) and   >  10-yr-old (  n   = 2) BM samples. (B) CD4, CD8, CD3, and        TCR 
expression analysis of 5-wk cultures on OP9-hDelta1 stromal cells of CD10  + CD24        progenitors sorted from cord blood or pediatric BM. The data shown 
represent fi  ve independent experiments performed on cord blood (  n   =  2)  and   < 10-yr-old  ( n   =  2)  and   > 10-yr-old  ( n   = 1) BM samples. After 5 wk, we 
recovered an average of 6,000 and 200 T cells (CD4  + CD8 +   and          T cells) from 1,000 CD10  + CD24        progenitors sorted from cord blood and BM samples, 
respectively. (C) Lin       CD34 + CD10 +   progenitors exhibit a DC potential. (left) A representative 10-d culture in DC differentiation conditions from 
cord  blood – sorted  CD10        and  CD10 + CD24        progenitors is shown. Bar, 10      m. In the same culture conditions, CD10  + CD24 +   cells did not survive. 
(right) Flow cytometry analysis of 10-d cultures of CD10         and  CD10 + CD24        progenitors. HLA-DR expression is analyzed on CD1a  +  -gated cells. Numbers 
in A  –  C represent percentages of cells. (D) Limiting dilution assay analysis of CD10  + CD24        progenitors sorted from cord blood (  n   = 2) and   <  10-yr-old (  n   =  1) 
and   > 10-yr-old  ( n   = 1) BM. After 4  –  5 wk of culture in 96-well plates, means of 20,000, 3,250, and 560 viable cells were recovered from 100 CD10  + CD24       
progenitors sorted from cord blood, pediatric, and adult BM samples, respectively.     JEM VOL. 204, December 24, 2007  3089
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that portion of the thymic Lin        CD34  +  CD10  +   cells expressed 
the CD7 marker and that the acquisition of CD7 corre-
lated with the progressive loss of CD10 expression (  Fig. 
3 C  ). CD10  +  CD24        CD7         cells (hereafter referred to as 
CD10  +  CD24         counterparts. To characterize more precisely 
the CD10  +  CD24         progenitor in the thymus, we performed 
colabeling with CD7, one of the earliest markers associ-
ated with T cell diff  erentiation (  27  ). It is interesting to note 
    Figure 3.         Flow cytometry analysis and differentiation potential of Lin            CD34  +   cells in adult blood and postnatal thymus.   (A)  CD34 +   enriched 
cells isolated from the blood of an adult healthy donor were stained with a combination of lineage (Lin) markers and anti-CD34, anti-CD7, and anti-CD10 
antibodies. Data are representative of 5 pediatric and 11 adult blood samples. (B) CD10  +   and  CD10        progenitors recovered from adult blood were plated in 
B/NK (left) or T (right) cell differentiation conditions. The culture was analyzed using fl  ow cytometry. The results of one out of four experiments are 
shown. (C) CD34  +  -enriched cells from postnatal thymus were stained with a combination of lineage (Lin) markers and anti-CD34, anti-CD7, anti-CD1a, 
and anti-CD10 antibodies. (left) Analysis of Lin and CD34 expression in CD34  +  -enriched thymocytes. (right) CD10/CD7 expression on gated Lin       CD34 +  
cells is shown. CD1a expression is analyzed on Lin       CD34 + CD10 + CD7        and  CD7 +   cells (histogram, bottom). Data are representative of 25 analyzed 
thymuses. (D) The lymphoid potential of Lin       CD34 + CD10 +   thymic progenitors. (left) Up to 8,000 Lin       CD34 + CD10 + CD7        thymic progenitors were plated 
in B/NK cell differentiation conditions and analyzed after 3 wk. (right) Flow cytometry analysis of a representative 5-wk culture on OP9-hDelta1 stromal cells 
from postnatal thymus-sorted Lin       CD34 + CD10 + CD7        cells. After 5 wk, we recovered an average of 4,000 T cells (CD4  + CD8 +   and          T cells) from 
500 CD10  + CD7        progenitors sorted from thymus samples. Numbers in A  –  D represent percentages of cells.     3090 HUMAN POSTNATAL LYMPHOID PROGENITORS | Six et al.
  Gene expression profi  ling of CD10  +   progenitor cells 
  To further characterize the CD10        , CD10  +  CD24        , and 
CD10  +  CD24  +   cell populations, we studied the expression of 
several genes involved in hematopoietic diff  erentiation. Using 
our previously described multiplex RT-PCR method, which 
enables the simultaneous analysis of multiple genes in very 
small samples (  31  ), we set up four distinct multiplex assays to 
simultaneously monitor the expression of two or three lineage-
specifi  c genes, together with the   28S   ribosomal RNA gene as 
an endogenous control (  Fig. 4  ).   
  Irrespective of their ontogenic origin, CD10         cells were 
the only ones to express the   GATA1   transcription factor 
(  Fig. 4, A and B  ). These cells frequently expressed the surrogate 
light chain of the pre-BCR (  Vpre-B  ), whereas other lym-
phoid-specifi  c genes were mostly absent. CD10  +  CD24  +   cells 
expressed lymphoid- (  IL-7R      ,   RAG1  , and   TdT  ) and B cell 
lineage  –   ( PAX5  ,  EBF1  , and  Vpre-B  ) specifi  c genes but did not 
express the T cell  –  specifi  c genes   CD3       or the pre-TCR       
chain (  pT      ). In contrast, the CD10  +  CD24         cells displayed a 
broad lymphoid profi  le because they highly expressed   CD3       
as well as B cell lineage  –  specifi  c genes. Nevertheless, unlike 
mouse CLP-2, they did not express pT      (  5  ) and resemble 
more, in terms of gene expression profi  le as well as diff  eren-
tiation potential, CCR9  +   multipotent progenitors and early 
lymphoid progenitors (ELPs) (  6, 7  ). Interestingly, only the 
CD24         fraction of the CD10  +   progenitors (which exhibits 
the broadest lymphoid potential) concordantly expressed 
IL-7R      and      c (unpublished data). This result fi  ts with several 
studies showing that acquisition of IL-7R      by the earliest 
human progenitors is accompanied by an increase in lymphoid 
potential (  3, 32, 33  ), and that CD34  +  CD19        IL-7R       +  cells do 
not express CD24 (  32  ). It remains to be investigated whether 
the IL-7R       –  associated cytokines IL-7 and thymic stromal 
lymphopoietin play a role in the generation, survival, and/or 
proliferation of the CD10  +  CD24         population. 
  Thymus-isolated CD10  +  CD7         cells expressed genes that 
are common to both the T and B cell diff  erentiation path-
ways but showed evidence of T cell commitment (  Fig. 4 C  ). 
Interestingly, they express IL-7R      chain, a result that con-
trasts with the absence of the IL-7R      chain observed in 
mouse ETP (  8, 10  ). Compared with their CD10  +  CD24         BM 
and cord blood counterparts, thymic CD10  +  CD7         cells rarely 
expressed B cell  –  specifi  c genes, whereas the activity of all T 
cell  –  specifi  c genes increased:   CD3      ,   GATA3  , and   pT      . It is 
noteworthy that gene expression profi  ling of the thymic 
CD10  +  CD7         population revealed down-regulation of B 
cell  –  specifi  c genes, an observation that correlates with a de-
creased ability to generate B cells in vitro. Conversely, we 
observed an up-regulation of the T cell  –  specifi  c genes. These 
singular features match the signals triggered by the thymic 
niche (i.e., the Notch signal), which may program the ETPs 
into T cell development (  34, 35  ). 
  Collectively, our results show that CD10  +  CD24         progen-
itors are present in the cord blood and in the BM through-
out life, and that cells with a similar phenotype circulate and are 
present in the thymus. Moreover, we have demonstrated that 
CD10  +  CD7         cells) thus constitute a weak portion of total 
CD34  +   thymic cells, explaining why they were not identifi  ed 
in previous studies (  23, 24  ). 
  Blood-sorted CD10  +   cells exhibited a signifi  cant lym-
phoid potential as compared with their CD10         counterparts. 
Indeed, no erythro-myeloid colonies were detected after semi-
solid cultures (not depicted), whereas they gave rise to B, 
NK, and T lymphocytes when cultured in appropriate condi-
tions (  Fig. 3 B  ). 
  When cultured in conditions of erythro-myeloid diff  eren-
tiation, thymic CD10  +  CD7         cells were found to have no ery-
throid and very low myeloid potential (unpublished data). 
Conversely, they retained the ability to differentiate into 
CD56  +   NK and CD19  +   B cells (  Fig. 3 D  ), although B cell 
potential required the seeding of a high number of progenitors 
(    10  4   cells) and was thus much lower than the ones found in 
the blood-, cord blood  –  , and BM-derived counterparts. When 
cultured on OP9-hDelta1 cells, thymic CD10  +  CD7         cells were 
able to generate CD4  +  CD8  +   double-positive cells as well as 
           and            T cells (  Fig. 3 D  ). Hence, like their BM counterparts, 
blood and thymic CD10  +  CD7         cells are highly lymphoid re-
stricted. We examined the T cell diff  erentiation potential of 
CD10  +  CD7         and CD10        CD7  +   thymocytes (  Table I  ).   CD10  +   
cells down-regulated the CD10 marker within 5 d and then 
started to express CD7 and CD5. Double-positive CD4  +  CD8  +   
and           TCR  +  CD3  +   T cells were detected from day 25 on. 
CD7  +   cells generated T cells much faster, because CD4  +  CD8  +   
and           TCR  +  CD3  +   T cells were already detected at day 15. 
Together with these kinetics of diff  erentiation, the thymic-
resident CD10  +  CD7         cells lacked CD1a ( Fig. 3 C ) and expressed 
only low levels of CD38 (not depicted). In contrast, a portion 
of thymic CD10        CD7  +   cells was CD1a  +   (  Fig. 3 C  ). These re-
sults suggest a continuum between CD10 +  CD7        , CD7 +  CD1a        , 
and CD7  +  CD1a  +   cells. CD10  +   cells precede the CD7  +   stage in 
the thymus and may therefore constitute the earliest thymic 
progenitor in the postnatal period (  24, 26  ). 
  Table I.        Kinetics of T cell differentiation of CD10  + CD7         and 
CD10  + CD7  +   thymus-sorted progenitors   
Days of  
  culture
Markers Plated progenitor cells (%    a    )
CD10  +  CD7       CD10        CD7  + 
5  CD10 3 0
 CD7 33.5 91
 CD5 15.5 83
15  CD7 89.5 98
 CD5 66.5 97
           TCR/CD3 0 0.4
 CD4/CD8 0.25 3.4
25            TCR/CD3 2.7 54
 CD4/CD8 2.4 20
  a  Mean percentages of CD10  + ,  CD7 + ,  CD5 + ,        TCR + CD3 + ,  and  CD4 + CD8 +   double-
positive cells after 5, 15, and 25 days of culture on OP9-hDelta1 stromal cells 
(measured in two independent experiments).JEM VOL. 204, December 24, 2007  3091
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Miltenyi Biotec), according to the manufacturer  ’  s instructions. Purifi  ed CD34  +   
cells or mononuclear BM cells were stained with anti-CD34  –  allophycocyanin 
(APC; 8G12). The lineage (Lin) PE-conjugated antibody cocktail contained 
antibodies against CD2 (S5.2), CD3 (SK7), CD4 (SK3), CD8 (SK1), CD19 
(J4.119), CD20 (L27), CD56 (NCAM16.2), CD13 (SJ1D1), CD14 (M     P9), 
CD15 (MMA), CD16 (NKP15), CD33 (HIM3-4), and CD235a (GA-R2). 
Additional markers were used for both phenotypic analysis and sorting: 
anti-CD10  –  PE-Cy7 (H10a), anti-CD7 –  FITC (M-T701), anti-CD1a –  APC 
(HI149), anti-CCR7  –  PE-Cy7 (3D12), purifi  ed anti-CCR9 (112509), and 
anti-CD24  –  FITC (ML5). All antibodies were obtained from BD Biosciences, 
Beckman Coulter, or R  &  D Systems. 
  Stained cells were either analyzed with a fl  ow cytometer (FACSCalibur) 
and CellQuest software, or sorted on a cell sorter (FACSVantage; all from 
BD Biosciences). The purity of sorted cells was routinely     98%. 
  In vitro diff  erentiation protocols.     DC potential was assessed as previously 
described (  36  ). Cultures were analyzed by fl  ow cytometry using a combina-
tion of anti-CD14  –  FITC, anti-CD1a  –  APC (HI149), ViaProbe (7-amino-
actinomycin D, to exclude dead cells from the analysis; BD Biosciences), and 
anti-CD80  –  PE (L307.4) or anti  –  HLA-DR  –  FITC (clone G46-6). 
  B and NK cell diff  erentiations were performed on a confl  uent stroma of 
nonirradiated MS5 cells (DSMZ ACC 441), as previously described (  13  ). 
Cultures were analyzed by fl  ow cytometry using a combination of anti-
CD19  –  APC, anti-IgM  –  PE, and either anti-CD45  –  PerCP or ViaProbe for B 
cell diff  erentiation and a combination of anti-CD56  –  PE and anti-CD45  –
  PerCP to evaluate NK cell diff  erentiation. 
  T lymphoid potential was tested by plating candidate progenitors on 
OP9 stromal cells (American Type Culture Collection) transduced with 
a defective retrovirus containing a double cassette expressing the human 
Notch ligand Delta1 (hDelta1) and GFP. The co-culture was performed 
as previously described (  19, 20  ). After 3  –  5 wk, a fraction of the culture was 
CD10  +  CD24         cells derived from BM and thymic CD10  +  CD7         
cells display very similar features in terms of their diff  erentiation 
potential, which is lymphoid biased, and RAG, TdT, CD3     , 
and IL-7R      expression levels. This observation strongly sug-
gests that the thymic CD10  +  CD7         population directly de-
rives from BM CD10  +  CD24         cells. We therefore suggest 
that CD10  +  CD24         progenitors constitute a thymus-seeding 
population and may replace CD7  +  CD45RA  +   cells in the 
postnatal period. Further characterization of CD10  +  CD24         
lymphoid progenitors and analysis of their expansion capacity 
should pave the way for their enrichment and potential use in 
a variety of immune restoration scenarios. 
  MATERIALS AND METHODS 
  Human cells and tissues.     Mononuclear BM cells corresponded to the 
unused, healthy residues of allogeneic, hematopoietic stem cell harvests. Cord 
blood samples were harvested on delivery of full-term, healthy pregnancies at 
the Intercommunal Hospital (Creteil, France) and the Saint-Vincent de Paul 
Hospital (Paris, France) after obtaining written, informed consent of the moth-
ers according to French legislation and ethical guidelines. Blood samples were 
obtained from healthy adult donors after obtaining written, informed consent 
from the French Blood Transfusion Institute (Paris, France). Human thymic 
tissue was obtained from children aged from 1 d to 10 yr of age undergoing 
cardiac surgery. Experimental procedures with human thymic fragments were 
approved by the human research Ethics Committees at the Oswaldo Cruz 
Foundation and the Necker Children  ’  s Hospital (Paris, France). 
  Phenotypic characterization and sorting of progenitors.     CD34  +   cells 
were isolated using an indirect CD34 microbead kit and a separator (VarioMACS; 
    Figure 4.         Gene expression profi  le of CD10           , CD10  +  CD24           , and CD10  +  CD24  +   progenitors.   (A) BM or (B) cord blood Lin       CD34 + CD10      , 
Lin       CD34 + CD10 + CD24       , and Lin       CD34 + CD10 + CD24 +   populations and (C) thymic Lin       CD34 + CD10 + CD24      CD7        cells were sorted directly into PCR tubes at 
10 cells per well. RT followed by a quadruplex or triplex amplifi  cation PCR assay was performed. Each well was duplicated to perform a second qualitative 
PCR, and seven or eight representative wells are presented for each population. DNA fragment sizes are indicated.     ,  negative  control.   3092 HUMAN POSTNATAL LYMPHOID PROGENITORS | Six et al.
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analyzed by fl  ow cytometry using the following antibodies: anti-          TCR  –
  PE (IMMU510), anti-          TCR  –  PE (T10B9.1A-31), anti-CD3  –  APC (SK7), 
anti-CD8  –  PE, and anti-CD4  –  APC (SK3). ViaProbe was added to all stain-
ings. In some cases, intermediate fl  ow cytometry analyses were performed 
by staining cultures with anti-CD5  –  FITC and anti-CD7  –  PE. As previ-
ously described, the OP9-hDelta1 assay consistently and rapidly gave rise 
to a high number of            T cells, with            T cells usually detected after 7 wk 
of culture (  19  ). 
  Limiting dilution assays.     Cells were seeded at 1, 3, 10, 30, and 100 cells 
per well into 24 wells (for each concentration) of either MS5- (for B and NK 
cell diff  erentiation) or OP9-hDelta1  –  coated 96-well plates (for T cell diff  er-
entiation) and cultured as described in the previous section. The presence of 
CD45  +  CD19  +   B, CD45  +  CD56  +   NK, or CD4  +  CD8  +   and CD3  +            TCR  +   
cells was determined by fl  ow cytometry in each well. Data are presented as 
percentages of negative wells according to the initial number of cells plated 
per well. An exponential curve fi  t was drawn for each type of precursor. The pro-
portion of lymphoid precursors was calculated by linear regression analysis 
(on the basis of a Poisson distribution) (  37  ). 
  Multiplex RT-PCR.     Multiplex RT-PCR analysis was performed accord-
ing to the method published by Peixoto et al. (  31  ), with minor modifi  ca-
tions. Our primers were designed using Primer3 software (frodo.wi.mit.edu), 
and primer compatibility for the multiplex analysis was assessed using 
Amplify freeware (version 3.1.4; engels.genetics.wisc.edu/amplify/). The 
absence of competition in the multiplex reactions was validated using quan-
titative PCR and by comparing individual and multiplex gene amplifi  cation. 
The primers selected for the PCR reactions are listed in Table S4 (available 
at http://www.jem.org/cgi/content/full/jem.20071003/DC1). Sorted cells 
were collected in individual PCR tubes containing PBS  –  diethyl pyrocar-
bonate (Sigma-Aldrich) and stored at      80  °  C. After cell lysis, RNA was re-
verse transcribed using three or four gene-specifi  c 3      primers. The fi  rst 
amplifi  cation PCR was subsequently performed in the same wells by addi-
tion of a premixed PCR buff  er containing 3      and 5      primers for all three or 
four genes and amplifi  ed for 15 cycles. The products of the fi  rst amplifi  cation 
were split into new PCR tubes using 4% of the fi  rst-round PCR product per 
reaction. This second PCR was performed separately for each individual 
gene using seminested primers. PCR products were resolved on a 2.5% aga-
rose ethidium bromide gel and were sequenced to confi  rm specifi  city. 
  Statistical analysis.     Data are expressed as mean   ±   SD and were statisti-
cally analyzed using an unpaired, two-tailed Student  ’  s   t   test with an       risk 
of 0.05. 
  Online supplemental material.     Fig. S1 shows fl  ow cytometry analysis of 
cord blood and postnatal BM progenitors. Fig. S2 illustrates the lymphoid 
potential of CD10  +   and CD10         progenitors. Table S1 shows the colony-
forming potential of CD10         and CD10  +   progenitors. Table S2 shows the 
generation of myeloid cells from CD10         and CD10  +   BM-sorted cells after 
culture on MS5 stromal cells. Table S3 shows the status of IgH recombina-
tion in BM-sorted CD10        , CD10  +  CD24        , and CD10  +  CD24  +   cells. Table 
S4 shows the various sets of primers used for multiplex RT-PCR assays. 
Supplemental material and methods provides information about in vitro dif-
ferentiation protocols and VDJ recombination. Online supplemental material 
is available at http://www.jem.org/cgi/content/full/jem.20071003/DC1. 
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